Cancer imaging and therapy with bispecific antibody pretargeting
- 1 March 2007
- journal article
- review article
- Published by Elsevier in Update on Cancer Therapeutics
- Vol. 2 (1), 19-31
- https://doi.org/10.1016/j.uct.2007.04.003
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targetingProceedings of the National Academy of Sciences, 2006
- Antibody Pretargeting Advances Cancer Radioimmunodetection and RadioimmunotherapyJournal of Clinical Oncology, 2006
- The Progress and Promise of Molecular Imaging Probes in Oncologic Drug DevelopmentClinical Cancer Research, 2005
- Engineering novel binding proteins from nonimmunoglobulin domainsNature Biotechnology, 2005
- Recombinant approaches to IgG-like bispecific antibodiesActa Pharmacologica Sinica, 2005
- A Novel Bispecific Tetravalent Antibody Fusion Protein to Target Costimulatory Activity for T-cell Activation to Tumor Cells Overexpressing ErbB2/HER2Journal of Molecular Biology, 2005
- The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructsNuclear Medicine and Biology, 2005
- 131I Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade Malignant Glioma: Phase I and II StudyActa Oncologica, 1999
- Successful Radioimmuno-therapy for Lung Metastasis of Human Colonic Cancer in Nude MiceJNCI Journal of the National Cancer Institute, 1991
- Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticalsInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986